IN-DATE
NDC 50419-325-18: Bayer Gadavist (Gadobutrol) Injection 30ml Vials Bulk Packaging
Photos are for illustration purposes only and may not depict the exact item.
Sign in to add this product to your favorites!
| Price: | $999.00 per box of 10 |
|---|---|
| In Stock: | 0 box of 10 |
| Expiration: | In-Date |
We currently do not have this item in stock, but we can email you as soon as it is available.
Additional Details
Bayer Gadavist (Gadobutrol) Contrast Media
- GADAVIST™ is a gadolinium-based contrast agent indicated for intravenous use in diagnostic magnetic resonance imaging (MRI) in adults and children (2 years of age and older) to detect and visualize areas with disrupted blood brain barrier (BBB) and/or abnormal vascularity of the central nervous system
- Gadavist is formulated at a higher concentration (1 mmol/mL) compared to certain other gadolinium-based contrast agents, resulting in a lower volume of administration
- Gadavist injection contains 1 mmol gadobutrol/mL (equivalent to 604.72 mg gadobutrol/mL)
- Store at 25°C (77°F); excursions permitted to 15 - 30°C (59 - 86°F)
Manufacturer
Medrad, now part of Bayer HealthCare, specializes in medical imaging solutions, particularly contrast injection systems used in radiology and cardiology. Their product portfolio includes injectors for computed tomography (CT), magnetic resonance imaging (MRI), and angiography, such as the Stellant CT injection system, Spectris Solaris EP MR injector, and the Mark 7 Arterion angiography injector. Medrad also offers disposables and software solutions designed to optimize imaging procedures, improve workflow efficiency, and enhance patient safety through precise and reliable contrast delivery.
